Corporate-led funding rounds account for larger and larger shares of total venture investment. The trend is here to stay as CVC offers startups more than just money.
Author: Bill Taranto, founder and president, MSD Global Health Innovation Fund
The virtual state of corporate venture today
Comment from Bill Taranto, founder and president, Merck Global Health Innovation Fund
Getting to scale and long-term staying power
Perspective from a CVC practice innovator by Bill Taranto, president, Merck GHIF
Next generation corporate VCs are here to stay
This week for our main comment we republish an article by Bill Taranto, the head of Merck’s Global Health Innovation fund, on how corporate VCs are here to stay.